logo
San Francisco pharmacy established in 1908 will close its doors in July

San Francisco pharmacy established in 1908 will close its doors in July

CBS News24-06-2025
It's the end of an era for one longtime pharmacy drugstore in San Francisco.
Central Drug Store in the Excelsior District will be closing its doors on July 15 after over 100 years. Owner Jerry Tonelli announced he will be retiring.
"This is my father here, Dino Tonelli. He started working here in 1949 after he graduated from pharmacy school at UCSF. And he was a WW2 veteran," Jerry Tonelli, the pharmacist owner of Central Drug Store, told CBS News Bay Area.
Generations of San Franciscans have picked up their prescriptions since the pharmacy first opened in 1908, and it's been at the 4494 Mission Street location since 1918, according to its Legacy Business Registry application.
"You come in, you know these people, you know their children," Tonelli said. "Sometimes you feel like you're a priest or psychiatrist because they come in with problems, and you try to help them out."
The business is also the scene of a sweet love story: His parents met at the drug store, as his mother was also an employee.
"My mother started working here when she was 16, and she died in 2023 at the age of 96. So, she had quite a run here, and this was her favorite part of the store because she used to do all the buying for the cosmetics, for the perfumes," Tonelli said.
His parents eventually took ownership of the pharmacy and have been prominent community members.
"I was only in my 30s when my father passed away, and all of a sudden, to take over the business and run it, was learning by trial and error," Tonelli said.
He adds that it has been a great run, meeting new friends along the way.
"We get a lot of people from other countries that don't have health insurance and don't want to see a doctor. They'll come in and ask this and ask that and try to treat them with over-the-counter medication to help them out," he said.
And now, he shared that his decision to close is bittersweet. Tonelli said he is concerned about independent pharmacies that are essentially being forced out by corporations.
"The city started letting Walgreens come into the city, and what happened then was they usually opened up next to the independent, and eventually the independent had to close," he said.
Fran Colombo, who has been going to Central Drug Store for the past 50 years, has been hit hard by the news of the closure.
She said the Tonelli family has become great friends throughout the years.
"They make everybody feel that walks through that door, that they're special," Colombo said. "There are just no words to explain the love that they give out. And in turn, you give it back to them."
She shared how Tonelli had helped her late husband when he was picking up his medications.
"When he came out, Jerry had his arm and was walking him to our car. And I will never forget that. That is what you call going above and beyond," Colombo said.
She added that it is concerning for older patients in the community who don't have many resources to access the healthcare they need.
"I'm kind of computer savvy, but what about the people who aren't, who are just used to the walking in and calling in a prescription and walking in and picking it up? What are they going to do?" Colombo said.
She said that she will cherish all the memories that she and her family made along the way at their pharmacy. And in the meantime, Tonelli plans to continue providing the best care while he is still open.
He added, he is also looking forward to spending time with his family and sharpen his golf skillsets. Tonelli wanted to share that his passion to serve won't stop.
"Try to do some volunteer work somewhere and try to help the people out at a hospital or a shelter," he said.
Until he writes his last prescription, Tonelli will be right here opening his doors with a smile, like he's been doing all this time.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Here's what Warren Buffett says will be the ultimate growth industry!
Here's what Warren Buffett says will be the ultimate growth industry!

Yahoo

time9 minutes ago

  • Yahoo

Here's what Warren Buffett says will be the ultimate growth industry!

Artificial intelligence (AI) has a lot of investors excited right now, yet billionaire investor Warren Buffett isn't one of them. Despite owning shares in companies such as Apple (NASDAQ:AAPL) and Amazon, none of these investments were made solely based on their AI potential. In fact, Buffett seems to be quite cautious of the technology. Instead, he's warned investors that AI will give rise to an enormous amount of fraud, making scamming the biggest 'growth industry of all time'. Sticking to his principles Despite his hesitant stance, Buffett isn't blind to the benefits of this emerging technology. In the right hands, AI can be a remarkable tool with countless applications in finance, cybersecurity, automation, and work productivity among others. However, with so many businesses claiming to be the next big thing, Buffett and his team are remaining disciplined. They're focusing on the industries they understand the most, zooming in on the businesses with the widest competitive moats. That means rather than chasing speculative AI stocks, he's looking at the established players across the sectors that can leverage AI to improve their existing operations, using the proceeds to run phenomenal capital-return programmes. And right now, Apple seems to fit that bill. Exploring Apple's potential While Buffett's investment vehicle Berkshire Hathaway has trimmed its position in Apple throughout last year, it remains one of its largest holdings, representing 24% of the portfolio. As one of the largest consumer technology companies in the world, Apple produces an enormous amount of free cash flow driven by a loyal customer ecosystem. Since 2013, the company's been busy consistently buying back its own shares, with around $775bn spent over the last 12 years. To put this into perspective, that's enough money to buy the entirety of Visa with another $100bn to spare. And with management approving yet another $100bn in buybacks during 2025, the rewards for shareholders look set to continue, especially if the firm can deliver on its AI ambitions. So far, Apple has lagged when it comes to AI implementation. The rollout of Apple Intelligence has actually been quite slow and riddled with delays, which have seemingly continued into 2025. And the ongoing trade disruptions from newly-announced US tariffs aren't exactly helping matters, which have led to around a quarter of Apple's market-cap being lost in 2025. However, that might soon change. The company has a record number of revamped product launches in the second half of 2025. That includes four new iPhone models, and updates for its AirPods, Apple Watches, iPads, and MacBooks. And with plans to hire another 20,000 people over the next four years to expand its R&D capabilities, the firm might soon be catching up on the AI front, generating even more cash flow over the long run. Perhaps that's why Buffett continues to hold a significant chunk of shares. And it's why I think investors may want to take a closer look at this business. The post Here's what Warren Buffett says will be the ultimate growth industry! appeared first on The Motley Fool UK. More reading 5 Stocks For Trying To Build Wealth After 50 One Top Growth Stock from the Motley Fool Zaven Boyrazian has no position in any of the shares mentioned. The Motley Fool UK has recommended Apple. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. Motley Fool UK 2025

Better Energy Stock: Diamondback Energy vs. Chevron
Better Energy Stock: Diamondback Energy vs. Chevron

Yahoo

time9 minutes ago

  • Yahoo

Better Energy Stock: Diamondback Energy vs. Chevron

Key Points Chevron's integrated business and its rock-solid balance sheet help secure its dividend. Diamondback Energy is a well-run oil and gas company that offers good upside due to the potential for higher oil prices. Ultimately, the decision comes down to each individual's risk profile, but one stock stands out as a clear winner for passive income-seeking investors. 10 stocks we like better than Diamondback Energy › Comparing a pure-play exploration and production in the Permian Basin, Diamondback Energy (NASDAQ: FANG), with an integrated energy major, Chevron (NYSE: CVX), sheds light on many of the questions that oil and gas-focused investors face in the coming years. Let's take a look at which company might suit which type of investor better. The role of oil prices There's no getting around this question when investing in energy stocks, but the answers to it may not be immediately apparent. It's important to note that both these companies are very well run and pride themselves on a relatively low operating "break-even" oil price. This price represents the lowest price of oil needed to cover the cost of the company's operating expenses, existing wells (maintenance capital spending), and base dividend. Chevron's break-even price for oil is in the $30 per barrel range accoring to a Wood Mackenzie survey. Diamondback's management estimates its equivalent break-even price is $37 per barrel. That would appear to give Chevron the upper hand. However, consider that Chevron is an integrated major with substantial downstream and chemicals operations, which tend to perform well with a lower oil price; these factors are included in the break-even calculation. On the other hand, Diamondback is purely an exploration and production company. Moreover, Diamondback utilizes hedging to mitigate downside exposure to oil prices. Its hedges currently apply down to a price of oil of about $55 per barrel, meaning it has upside exposure to a price of oil above $55 per barrel. As such, you can think of Chevron's dividend (currently yielding 4.8%) as safe down to $30 per barrel, and Diamondback's base dividend (currently yielding 2.9%) as safe down to $37 per barrel. Consequently, if you are the type of investor primarily looking for yield and wanting to sleep safely at night, Chevron is the better investment for you. Don't forget the upside The flip side of the argument is that Diamondback has more exposure to a higher oil price, which is what one might expect, given that it's an exploration and production company. To provide some context for how this works, here's a look at Diamondback's management's estimated adjusted 2025 free cash flow (FCF) across a range of oil prices. For reference, Diamondback aims to return 50% of FCF to shareholders in the form of dividends (base and variable) and share buybacks. It has $1.845 billion remaining as part of a $6 billion share buyback authorization program. As of its first quarter, Diamondback made $829 million in share buybacks, equivalent to about $2.80 per share. Therefore, if management decided not to make any more buybacks and pay the remaining 50% in full-year FCF in dividends (base of $4, plus a variable dividend), then it could offer $5.20 in dividends, yielding 3.8%, assuming a price of oil of $60 a barrel. That theoretical figure rises $8.70 in dividends, yielding 6.4%, assuming a price of $80 a barrel. See what I mean by Diamondback having more upside exposure to the price of oil? Price of Oil per Barrel Free Cash Flow Free Cash Flow Per Share Free Cash Flow Yield (based on the current market price of Diamondback Energy of $136.5 a share) $50 per barrel $4.15 billion $14 10.3% $60 per barrel $4.85 billion $16 11.7% $70 per barrel $5.85 billion $20 14.7% $80 per barrel $6.85 billion $23 16.8% Data source: Diamondback Energy presentations. Table by author. In case you are wondering, based on these assumptions, the price of oil would have to be approximately $67 per barrel to get Diamondback's dividend yield to be equivalent to Chevron's current yield -- curiously enough, that's roughly the current price of oil now. Diamondback or Chevron? Ultimately, dividend-focused investors and those concerned about being overly exposed to oil prices will favor Chevron. In addition, Chevron's diversified operations (its production in the Permian is comparable to Diamondback's, but it has substantial other global assets, plus midstream and downstream operations) give it a place to focus its investment, even in the event of a sustained fall in oil prices. In contrast, other than reducing capital investment in response to lower prices (something Diamondback has already done this year), it's hard to think of what significant move a company like Diamondback can make. That said, many investors buy oil stocks precisely because they want exposure to the upside of oil, and Diamondback is a high-quality operator that has taken measures to limit its downside exposure. As such, nothing is stopping you from buying both stocks, as they are both attractive for passive income-seeking investors. Should you buy stock in Diamondback Energy right now? Before you buy stock in Diamondback Energy, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Diamondback Energy wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $652,133!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,056,790!* Now, it's worth noting Stock Advisor's total average return is 1,048% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 15, 2025 Lee Samaha has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Chevron. The Motley Fool has a disclosure policy. Better Energy Stock: Diamondback Energy vs. Chevron was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

What You Need to Know Ahead of Cognizant Technology's Earnings Release
What You Need to Know Ahead of Cognizant Technology's Earnings Release

Yahoo

time17 minutes ago

  • Yahoo

What You Need to Know Ahead of Cognizant Technology's Earnings Release

With a market cap of $37.3 billion, Cognizant Technology Solutions Corporation (CTSH) is a leading global provider of IT consulting, business process services, and outsourcing solutions. Headquartered in Teaneck, New Jersey, the company operates through four segments: Financial Services; Health Sciences; Products and Resources; and Communications, Media and Technology. CTSH is expected to report its Q2 earnings on Wednesday, July 30, after the market closes. Ahead of the event, analysts expect CTSH to report an EPS of $1.26 per share, up 7.7% from a profit of $1.17 per share reported in the year-ago quarter. It has exceeded analysts' earnings estimates in all of the past four quarters. More News from Barchart Warren Buffett's Berkshire Hathaway Earns $93,150 Every Hour from Coca-Cola Dividends Alone OpenAI CEO Sam Altman Calls DeepSeek's Bluff: 'I Don't Think They Figured Out Something Way More Efficient' These Are the Highest Yielding Dividend Aristocrats Today (Entire List) Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, analysis, and headlines. For the current year, analysts expect CTSH to report an EPS of $5.08, up 7% from $4.75 in fiscal 2024. Over the past year, CTSH shares have fallen marginally, underperforming the S&P 500 Index's ($SPX) 13.6% gains but outperforming the Technology Select Sector SPDR Fund's (XLK) 16.3% returns over the same time frame. On April 30, shares of Cognizant surged marginally following the release of its Q1 results. The company reported an adjusted EPS of $1.23, surpassing the Street's estimate of $1.19, while revenue came in at $5.12 billion, ahead of the projected $5.07 billion. For the full year, Cognizant expects adjusted EPS to range between $4.98 and $5.14, with revenue guidance set between $20.5 billion and $21 billion. Moreover, analysts remain fairly upbeat about CTSH stock's future prospects, with a "Moderate Buy" rating overall. Among 24 analysts covering the stock, seven recommend a 'Strong Buy,' one suggests a 'Moderate Buy,' and 16 suggest a 'Hold.' Its mean price of $89.79 implies a premium of 18.6% from its prevailing price level. On the date of publication, Kritika Sarmah did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store